Amanote Research

Amanote Research

    RegisterSign In

Dosage of Angiotensin Converting Enzyme Inhibitors

BMJ
doi 10.1136/bmj.311.6996.59
Full Text
Open PDF
Abstract

Available in full text

Date

July 1, 1995

Authors
J. Mcmurray
Publisher

BMJ


Related search

Angiotensin Converting Enzyme (ACE) Inhibitors

Annual Review of Pharmacology and Toxicology
ToxicologyPharmacology
1982English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin Converting Enzyme Inhibitors for Cancer Treatment?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2004English

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

N-Protected Tripeptide Inhibitors of Angiotensin Converting Enzyme.

Agricultural and Biological Chemistry
1990English

Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Antioxidant Power of Angiotensin-Converting Enzyme Inhibitors in Vitro

British Journal of Clinical Pharmacology
Pharmacology
1998English

Development of Domain-Selective Angiotensin I-Converting Enzyme Inhibitors

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy